These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28666620)

  • 1. Targeting the ubiquitin proteasome system in diabetic cardiomyopathy.
    Bozi LHM; Campos JC
    J Mol Cell Cardiol; 2017 Aug; 109():61-63. PubMed ID: 28666620
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac proteasome functional insufficiency plays a pathogenic role in diabetic cardiomyopathy.
    Li J; Ma W; Yue G; Tang Y; Kim IM; Weintraub NL; Wang X; Su H
    J Mol Cell Cardiol; 2017 Jan; 102():53-60. PubMed ID: 27913284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteasome dysfunction in cardiomyopathies.
    Gilda JE; Gomes AV
    J Physiol; 2017 Jun; 595(12):4051-4071. PubMed ID: 28181243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitin-proteasome system and hereditary cardiomyopathies.
    Schlossarek S; Frey N; Carrier L
    J Mol Cell Cardiol; 2014 Jun; 71():25-31. PubMed ID: 24380728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ubiquitin proteasome system in human cardiomyopathies and heart failure.
    Day SM
    Am J Physiol Heart Circ Physiol; 2013 May; 304(10):H1283-93. PubMed ID: 23479263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitin-proteasome system impairment caused by a missense cardiac myosin-binding protein C mutation and associated with cardiac dysfunction in hypertrophic cardiomyopathy.
    Bahrudin U; Morisaki H; Morisaki T; Ninomiya H; Higaki K; Nanba E; Igawa O; Takashima S; Mizuta E; Miake J; Yamamoto Y; Shirayoshi Y; Kitakaze M; Carrier L; Hisatome I
    J Mol Biol; 2008 Dec; 384(4):896-907. PubMed ID: 18929575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ubiquitin-proteasome system in cardiomyopathies.
    Schlossarek S; Carrier L
    Curr Opin Cardiol; 2011 May; 26(3):190-5. PubMed ID: 21415726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SUMOylation: a novel protein quality control modifier in the heart.
    Maejima Y; Sadoshima J
    Circ Res; 2014 Sep; 115(8):686-9. PubMed ID: 25258400
    [No Abstract]   [Full Text] [Related]  

  • 9. The ubiquitin-proteasome system in cardiac proteinopathy: a quality control perspective.
    Su H; Wang X
    Cardiovasc Res; 2010 Jan; 85(2):253-62. PubMed ID: 19696071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ubiquitin-proteasome system facilitates the transfer of murine coronavirus from endosome to cytoplasm during virus entry.
    Yu GY; Lai MM
    J Virol; 2005 Jan; 79(1):644-8. PubMed ID: 15596861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ubiquitin-proteasome pathway].
    Xiao BY; Li GY
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 29(2):230-2. PubMed ID: 16145924
    [No Abstract]   [Full Text] [Related]  

  • 12. [The regulatory mechanisms of protein expression in heart failure patients' cardiomyocytes. The ubiquitin-proteasome system. Autophagy].
    Pawlak A; Bil J; Gil RJ
    Kardiol Pol; 2012; 70(11):1170-6. PubMed ID: 23180530
    [No Abstract]   [Full Text] [Related]  

  • 13. The bitter end: the ubiquitin-proteasome system and cardiac dysfunction.
    Patterson C; Ike C; Willis PW; Stouffer GA; Willis MS
    Circulation; 2007 Mar; 115(11):1456-63. PubMed ID: 17372187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the ubiquitin-proteasome system in carotid plaque instability in diabetic patients.
    Marfella R; Cacciapuoti F; Grassia A; Manfredi E; De Maio G; Caruso G; Pepe M; Nittolo G; Cacciapuoti F
    Acta Cardiol; 2006 Dec; 61(6):630-6. PubMed ID: 17205920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degradation of misfolded protein in the cytoplasm is mediated by the ubiquitin ligase Ubr1.
    Eisele F; Wolf DH
    FEBS Lett; 2008 Dec; 582(30):4143-6. PubMed ID: 19041308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Search and destroy: the role of protein quality control in maintaining cardiac function.
    Patterson C
    J Mol Cell Cardiol; 2006 Apr; 40(4):438-41. PubMed ID: 16516914
    [No Abstract]   [Full Text] [Related]  

  • 17. The ubiquitin-proteasome system may be involved in the pathogenesis of hypertrophic cardiomyopathy.
    Vosberg HP
    Cardiovasc Res; 2005 Apr; 66(1):1-3. PubMed ID: 15769440
    [No Abstract]   [Full Text] [Related]  

  • 18. Failure of ubiquitin proteasome system: risk for neurodegenerative diseases.
    Zheng C; Geetha T; Babu JR
    Neurodegener Dis; 2014; 14(4):161-75. PubMed ID: 25413678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lead discovery and chemical biology approaches targeting the ubiquitin proteasome system.
    Akinjiyan FA; Carbonneau S; Ross NT
    Bioorg Med Chem Lett; 2017 Oct; 27(20):4589-4596. PubMed ID: 28911816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TWIST1 regulates the activity of ubiquitin proteasome system via the miR-199/214 cluster in human end-stage dilated cardiomyopathy.
    Baumgarten A; Bang C; Tschirner A; Engelmann A; Adams V; von Haehling S; Doehner W; Pregla R; Anker MS; Blecharz K; Meyer R; Hetzer R; Anker SD; Thum T; Springer J
    Int J Cardiol; 2013 Sep; 168(2):1447-52. PubMed ID: 23360823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.